SCG-25535-31131 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-02
Dose 1 — Janssen/Johnson & Johnson
2021-06-12
Registered in v-safe
2021-10-03
Health check-in — 6 months, dose 1, dependent
Feeling: Good

Adult check-in
2021-12-18
Dose 2 — Pfizer-BioNTech
2022-01-15
Survey response — day 28, dose 2, dependent
MedDRA: Pain, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Mild fever, moderate aches & pains, severe congestion. Negative rapid test x 2

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Survey response — day 35, dose 2, dependent
MedDRA: Fatigue, Headache, Respiratory tract congestion — Feeling: Fair

Free text: mild fatigue, moderate congestion. Headache.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-02	Janssen/Johnson & Johnson
2	2021-12-18	Pfizer-BioNTech	No

Free text

Release 10 — day 28, dose 2, dependent

2022-01-15

Symptoms: Mild fever, moderate aches & pains, severe congestion. Negative rapid test x 2

Release 11 — day 35, dose 2, dependent

2022-01-22

Symptoms: mild fatigue, moderate congestion. Headache.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release